Efficacy, immunogenicity, and safety of the 9-valent human papillomavirus vaccine in males aged 16–26 years in Japan: a randomised, double-blind, placebo-controlled trial
- DOI
- 10.1016/s1473-3099(26)00291-4
- Published
- 2026-08
- Container
- The Lancet Infectious Diseases
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/s1473-3099-26-00291-4,
title = {Efficacy, immunogenicity, and safety of the 9-valent human papillomavirus vaccine in males aged 16–26 years in Japan: a randomised, double-blind, placebo-controlled trial},
author = {Koji Hisamoto and Masaki Yamanaka and Masayasu Nomura and Nobufumi Kanno and Anna R Giuliano and Keiko Wan and Yukako Fukao and Nobuyuki Oshima and Akira Wakana and Yoshiyuki Tanaka and Alain Luxembourg and Miyuki Sawata},
year = {2026},
journal = {The Lancet Infectious Diseases},
doi = {10.1016/s1473-3099(26)00291-4},
url = {https://doi.org/10.1016/s1473-3099(26)00291-4}
}RIS
TY - JOUR TI - Efficacy, immunogenicity, and safety of the 9-valent human papillomavirus vaccine in males aged 16–26 years in Japan: a randomised, double-blind, placebo-controlled trial AU - Koji Hisamoto AU - Masaki Yamanaka AU - Masayasu Nomura AU - Nobufumi Kanno AU - Anna R Giuliano AU - Keiko Wan AU - Yukako Fukao AU - Nobuyuki Oshima AU - Akira Wakana AU - Yoshiyuki Tanaka AU - Alain Luxembourg AU - Miyuki Sawata PY - 2026 JO - The Lancet Infectious Diseases DO - 10.1016/s1473-3099(26)00291-4 UR - https://doi.org/10.1016/s1473-3099(26)00291-4 ER -
APA
Hisamoto, K., Yamanaka, M., Nomura, M., Kanno, N., Giuliano, A. R., Wan, K., Fukao, Y., Oshima, N., Wakana, A., Tanaka, Y., Luxembourg, A., & Sawata, M. (2026). Efficacy, immunogenicity, and safety of the 9-valent human papillomavirus vaccine in males aged 16–26 years in Japan: a randomised, double-blind, placebo-controlled trial. The Lancet Infectious Diseases. https://doi.org/10.1016/s1473-3099(26)00291-4
Source records
- crossref · retrieved 2026-09-26T23:02:22.634Z